Danish Researchers Confirm Police Seizure of Hepatitis B Vaccines in Guinea-Bissau
A police operation in Guinea-Bissau has led to the seizure of hepatitis B vaccines intended for a controversial clinical trial, according to Danish researchers.
Danish researchers confirmed police sealed vaccines for a hepatitis B study in Guinea-Bissau.
The World Health Organization criticized the study's ethical implications, highlighting potential harm to newborns.
Guinea-Bissau's government has not authorized the clinical trial, despite ethical approvals.
A team of Danish researchers has confirmed that police in Guinea-Bissau conducted a search of their facilities, resulting in the seizure of hepatitis B vaccines intended for a controversial clinical trial. The incident occurred on Monday at the Bandim Health Project, where authorities sealed off the refrigerator containing the vaccines meant for the HBV-NSE study. Christine Stabell Benn, one of the project leaders, emphasized that the study had not yet commenced and that no children had been enrolled or vaccinated, indicating that the police action did not disrupt an ongoing trial.
The planned clinical study aimed to involve 14,000 newborns, with only a subset receiving the hepatitis B vaccine at birth. This approach has drawn criticism from the World Health Organization, which labeled it unethical. The WHO expressed concerns that withholding the vaccine from some participants could expose newborns to severe health risks, including chronic infections and liver-related diseases. The ethical implications of the study have raised alarms within the scientific community, particularly given the researchers' previous investigations into vaccine safety.
Despite having received ethical approval from both Guinea-Bissau's national ethics committee and the University of Southern Denmark's Research Ethics Committee, Stabell Benn clarified that these approvals do not substitute for the necessary governmental authorization to initiate the study. On October 16, Guinea-Bissau's Council of Ministers reiterated its refusal to allow the study to proceed under the proposed protocol, which is crucial for the trial funded by the US Centers for Disease Control and Prevention.
The hepatitis B infection rate in Guinea-Bissau is a significant public health concern, with over 12% of adults affected by chronic hepatitis B. The infection rate among children under five years old was reported at approximately 2% in 2020, exceeding global health targets. The ongoing situation raises questions about the balance between research and ethical responsibility in public health interventions.
Looking ahead, the Danish research team faces challenges in obtaining the necessary governmental approvals to move forward with their study. The implications of this incident extend beyond the immediate trial, highlighting the complexities of conducting clinical research in regions with high disease burdens and the ethical considerations that must be navigated to protect vulnerable populations.
